Literature DB >> 28559990

Macrophages activating chemokine (C-X-C motif) ligand 8/miR-17 cluster modulate hepatocellular carcinoma cell growth and metastasis.

Zi Yin1, Jianyu Huang1, Tingting Ma2, Dezhi Li1, Zhongshi Wu1, Baohua Hou1, Zhixiang Jian1.   

Abstract

Macrophages are a major component of tumor stroma and the infiltrated macrophages in malignant tumor tissues (as called tumor associated macrophages, TAM) play a pivotal role in hepatocellular carcinoma (HCC) progression. However, the molecular mechanisms of macrophages promoting HCC metastasis are poorly understood. The study was to investigate the effects of macrophages on liver cancer cell proliferation and metastasis through chemokine (C-X-C Motif) Ligand 8 (CXCL8). We found that macrophages activated by co-cultured liver cancer cells produced higher levels of CXCL8, which accelerated cell growth and metastasis. The expression of miR-18a and miR-19a (belonging to miR-17 cluster) increased in HCC cells by CXCL8 simulation and led to the enhancement of HCC cell proliferation and metastasis. In a conclusion, HCC cells and macrophages interaction promoted cancer cell proliferation and metastasis through the up-regulation of CXCL8/miR-17 cluster.

Entities:  

Keywords:  CXCL8; hepatocellular carcinoma; macrophages; miR-17 cluster

Year:  2017        PMID: 28559990      PMCID: PMC5446522     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  19 in total

1.  Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.

Authors:  Zhi-Yong Huang; Bin-Yong Liang; Min Xiong; Da-Qian Zhan; Shuang Wei; Guo-Ping Wang; Yi-Fa Chen; Xiao-Ping Chen
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

2.  Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.

Authors:  Weiyuan Fang; Lei Ye; Liyun Shen; Jie Cai; Fengjiao Huang; Qing Wei; Xiaochun Fei; Xi Chen; Haixia Guan; Weiqing Wang; Xiaoying Li; Guang Ning
Journal:  Carcinogenesis       Date:  2014-03-06       Impact factor: 4.944

3.  CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis.

Authors:  You-Chuan Xiao; Zhi-Bin Yang; Xian-Shuo Cheng; Xing-Bao Fang; Tao Shen; Cui-Feng Xia; Ping Liu; Hai-Hua Qian; Bin Sun; Zheng-Feng Yin; Yun-Feng Li
Journal:  Cancer Lett       Date:  2015-02-14       Impact factor: 8.679

4.  Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.

Authors:  Huan Tong; Jie-Qi Ke; Fei-Zhou Jiang; Xiao-Jun Wang; Fang-Yuan Wang; Yi-Ran Li; Wen Lu; Xiao-Ping Wan
Journal:  Cancer Lett       Date:  2016-03-24       Impact factor: 8.679

Review 5.  Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer.

Authors:  Jia Zhang; Hongmei Yao; Ge Song; Xia Liao; Yao Xian; Weimin Li
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 6.  Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.

Authors:  Yoshihiro Komohara; Yukio Fujiwara; Koji Ohnishi; Motohiro Takeya
Journal:  Adv Drug Deliv Rev       Date:  2015-11-24       Impact factor: 15.470

7.  Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.

Authors:  Lihua Li; Zijan Guo; Juanhua Wang; Yong Mao; Qi Gao
Journal:  Dig Dis Sci       Date:  2012-08-05       Impact factor: 3.199

8.  MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.

Authors:  Wan-Hsin Liu; Shiou-Hwei Yeh; Cho-Chun Lu; Sung-Liang Yu; Hsuan-Yu Chen; Chien-Yu Lin; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

9.  MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.

Authors:  Guifang Yu; Xuezhu Chen; Shudi Chen; Weipeng Ye; Kailian Hou; Min Liang
Journal:  J Transl Med       Date:  2016-05-05       Impact factor: 5.531

10.  ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.

Authors:  Seung Hyun Baik; Jongkuen Lee; Yeong-Shin Lee; Ji-Young Jang; Chul-Woo Kim
Journal:  Exp Mol Med       Date:  2016-03-25       Impact factor: 8.718

View more
  10 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

Review 2.  Macrophages and hepatocellular carcinoma.

Authors:  Zhiqiang Tian; Xiaojuan Hou; Wenting Liu; Zhipeng Han; Lixin Wei
Journal:  Cell Biosci       Date:  2019-09-26       Impact factor: 7.133

3.  Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.

Authors:  Helal F Hetta; Asmaa M Zahran; Reham I El-Mahdy; Emad Eldin Nabil; Hend M Esmaeel; Ola A Elkady; Azza Elkady; Dina A Mohareb; Mohammed Mahmoud Mostafa; James John
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01

4.  Decoding Immune Heterogeneity of Melanoma and identifying immune-prognostic hub genes.

Authors:  Yu Zhang; Siyu Hao; Yingli Gao; Weina Sun; Yuzhen Li
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

5.  Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC.

Authors:  Boris J B Beudeker; Zwier M A Groothuismink; Annemiek A van der Eijk; Jose D Debes; Andre Boonstra
Journal:  Cancers (Basel)       Date:  2022-10-07       Impact factor: 6.575

6.  M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.

Authors:  Xiaodong Qu; Xingyu Zhao; Kexin Lin; Na Wang; Xuezhi Li; Songbo Li; Luyao Zhang; Yongquan Shi
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

Review 7.  The emerging role of miR-19 in glioma.

Authors:  Weihan Wang; Anling Zhang; Yubing Hao; Guangxiu Wang; Zhifan Jia
Journal:  J Cell Mol Med       Date:  2018-08-02       Impact factor: 5.310

8.  Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.

Authors:  Xiaohui Tian; Yuanyuan Wu; Yating Yang; Jiaxin Wang; Menglan Niu; Shanjun Gao; Tao Qin; Dengke Bao
Journal:  Mol Oncol       Date:  2019-12-21       Impact factor: 6.603

Review 9.  Targeting tumor-associated macrophages to synergize tumor immunotherapy.

Authors:  Xiaonan Xiang; Jianguo Wang; Di Lu; Xiao Xu
Journal:  Signal Transduct Target Ther       Date:  2021-02-23

10.  Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment.

Authors:  Jukun Wang; Chao Zhang; Xin Chen; Yu Li; Ang Li; Dongbin Liu; Fei Li; Tao Luo
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.